Medline slips as sponsors look to cut stake in secondary offering
MDLN•Medline shares fell 4.6% premarket after selling stockholders launched a 60-million-share secondary offering. Medline also agreed to buy about $200 million of shares and common units from selling stockholders in a private transaction.
1. Sponsors sell shares
Selling stockholders including Blackstone, Carlyle Group, Hellman & Friedman, GIC Private and Abu Dhabi Investment Authority launched an offering of 60 million Medline shares. Blackstone and Hellman & Friedman are each selling 19 million shares, while Carlyle is selling 9.5 million.
2. Medline repurchase
Medline agreed to buy about $200 million of shares and common units from selling stockholders in a private, non-underwritten transaction. The company has 1.31 billion shares outstanding.
3. Shares and ratings
Medline shares fell 4.6% to $37.65 in premarket trading. Twenty-two of 28 brokerages rate the stock buy or higher, six rate it hold, and the median price target is $46. The stock was down 6% year to date as of the previous close.




